This poster explores how engineered chemistry, diverse building blocks and billion-scale library design create broad, drug-relevant chemical space in an off-the-shelf DEL platform.
Examples demonstrate how ReadiDEL screens have produced selective, structurally validated binders and supported progression from hit discovery to clinical candidates.